Access cutting-edge colorectal cancer treatment through this clinical trial at a research site in Denver. Study-provided care at no cost to qualified participants.
Access colorectal cancer specialists in Denver at no cost
This study follows strict safety protocols and ethical guidelines
All study-related colorectal cancer treatment provided free
This is an open-label multicenter, single-arm Phase II study of Fruquintinib in combination with FOLFIRI (leucovorin calcium (folinic acid), fluorouracil, and irinotecan) in participants with metastatic colorectal cancer (mCRC). The main goals of this study are to: * Evaluate the efficacy of the combination of fruquintinib + FOLFIRI in the 2nd-line mCRC setting * Evaluate the safety of the combination of fruquintinib + FOLFIRI
Sponsor: SCRI Development Innovations, LLC
Check if you qualify for this colorectal cancer clinical trial in Denver, CO
If you're searching for colorectal cancer treatment options in Denver, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Denver research site is actively enrolling participants for this clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.